Ads
related to: net did sars-cov-2acrobiosystems.com has been visited by 10K+ users in the past month
viroantibody.creative-biolabs.com has been visited by 10K+ users in the past month
Search results
How A New Covid-19 Antibody Could Contribute To Advanced Vaccine Development
Forbes· 5 days agoIn the ongoing Omicron era, a new Covid-19 antibody could renew optimism for urgently required SARS-...
National Academies Issue New Broad Definition of Long COVID
Medscape· 24 hours agoAccording to the 2024 NASEM definition of long COVID issued on June 11, 2024, "Long COVID is an...
How Messenger RNA Made The COVID Vaccines Possible
Science Friday· 5 days agoThe following is an excerpt from The Catalyst: RNA and the Quest to Unlock Life’s Deepest Secrets by Thomas R. Cech. On January 10, 2020, Prof. Yong-Zhen Zhang of Fudan University in Shanghai ...
CureVac (NASDAQ:CVAC) Sees Strong Trading Volume
ETF DAILY NEWS· 4 days agoCureVac (NASDAQ:CVAC – Get Free Report) saw strong trading volume on Thursday . 975,123 shares traded hands during mid-day trading, a decline of 0% from the previous session’s volume of 975,509 ...
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Northern Trust Corp
ETF DAILY NEWS· 2 days agoNorthern Trust Corp reduced its holdings in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 6.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,708,357 shares ...
COVID-19 Death Determination Methods, Minnesota, USA, 2020–2022
Centers for Disease Control and Prevention· 5 days agoIn addition, access to provisional death certificates is a consistently expeditious method for obtaining reports of potential COVID-19–associated deaths. In our analysis, median days between ...
Chronotherapy: Why Timing Drugs to Our Body Clocks May Work
Medscape· 2 days agoA new analysis published in this month's issue of The Lancet journal's eClinicalMedicine suggests:...
Parallel Advisors LLC Purchases 1,015 Shares of Xencor, Inc. (NASDAQ:XNCR)
ETF DAILY NEWS· 2 days agoParallel Advisors LLC increased its stake in Xencor, Inc. (NASDAQ:XNCR – Free Report) by 303.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,349 shares of the biopharmaceutical ...
TD Asset Management Inc Sells 56,914 Shares of Xencor, Inc. (NASDAQ:XNCR)
ETF DAILY NEWS· 4 days agoThe fund owned 123,250 shares of the biopharmaceutical company’s stock after selling 56,914 shares during the quarter. TD Asset Management Inc’s holdings in Xencor were worth $2< ...